RenalGuard system to prevent contrast-induced acute kidney injury in Japanese patients with renal dysfunction; RESPECT K
- PDF / 869,496 Bytes
- 8 Pages / 595.276 x 790.866 pts Page_size
- 97 Downloads / 119 Views
ORIGINAL ARTICLE
RenalGuard system to prevent contrast‑induced acute kidney injury in Japanese patients with renal dysfunction; RESPECT KIDNEY study Hiromasa Katoh1 · Tsuyoshi Nozue1 · Kazuki Horie2 · Takashi Sozu3 · Naoto Inoue2 · Ichiro Michishita1 Received: 21 December 2017 / Accepted: 2 May 2018 © Japanese Association of Cardiovascular Intervention and Therapeutics 2018
Abstract Increasing the urine flow rate (UFR) reduces the toxic effect of contrast media. Use of the RenalGuard system enables the achievement of a high UFR by maintaining intravascular volume and prevents the development of contrast-induced acute kidney injury (CI-AKI). However, the efficacy and safety of RenalGuard system have not yet been evaluated in Japan. This multicenter prospective study evaluated the efficacy and safety of the RenalGuard therapy in preventing CI-AKI development in 60 Japanese patients with renal dysfunction [estimated glomerular filtration rate (eGFR)
Data Loading...
